Total number of projects: 5
As coordinator: 2
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.67*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 1.469.100 | 734.550 | 1 | ||
2011 | 0 | 8.516.001 | 442.400 | 2 | ||
2010 | 3.697.596 | 0 | 702.182 | 2 |
Total number of partners: 762
Partner loyalty:
Frequent Partner: (> 2 projects): 196
Rare Partner: 566
Frequent / Rare Partner Ratio: 0.35
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-01-01 | Reverse engineering the vertebrate molecular machinery for magnetic biomineralisation | MAGNETOGENETICS | participant | 1.469.100 | 2 |
2011-02-01 | Targeting the tumour microenvironment to improve pancreatic cancer prognosis | EPC-TM-Net | participant | 3.000.000 | 17 |
2011-01-01 | Novel multimodal endoscopic probes for simultaneous PET/ultrasound imaging for image-guided interventions | EndoTOFPET-US | participant | 5.516.001 | 15 |
2010-09-01 | Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis | GAMBA | coordinator | 3.198.849 | 9 |
2010-09-01 | The impact of Regulation (EC) No 1394/2007 on the development of Advanced Therapy Medicinal Products (ATMPs): an academic perspective | Academic GMP | coordinator | 498.747 | 9 |